Venus Remedies gets nod from UK, New Zealand for antibiotic drug

16 Nov 2011 Evaluate

Drug firm Venus Remedies has received approvals from health authorities in the UK and New Zealand for marketing its generic injectable antibiotic Meropenem which is used for treating bacterial infections. The company has received approvals from Medicines and Healthcare products Regulatory Agency (MHRA) UK and New Zealand Ministry of Health for its generic Meropenem.

The drug will be launched in this fiscal year. Meropenem sales account for USD 906 million across the globe, which is estimated to grow to USD 1,006 million by 2012. The company is already selling the drug in various markets and is in the process of extending its sales in other regulated markets.

Venus Remedies Share Price

756.00 -11.00 (-1.43%)
01-Jan-2026 15:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.15
Dr. Reddys Lab 1252.65
Cipla 1501.55
Zydus Lifesciences 914.95
Lupin 2102.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×